Surprisingly, despite an important reduction of PAF‐AH activity in tumours (Figure2C), C26‐shPla2g7 mice only showed an around 20% decrease in plasma PAF‐AH activity levels (Figure2J), suggesting that tumour may not be the only contributor to the circulating amounts of PLA2G7 in cachectic mice. This evidence concerns the gene PLA2G7 and neoplasm.